Maya N. White

Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression

Maya N. White, Zofia Piotrowska, Kevin Stirling et al. · Clinical Lung Cancer · 2021 · 42 citations · Full text

Medicine, Oncology, Pharmacology +11

Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer

Jessica A. Hellyer, Maya N. White, Rebecca M. Gardner et al. · Clinical Lung Cancer · 2021 · 26 citations

Medicine, Molecular Genetics, Oncology +17

Caregiving, Transport-Related, and Demographic Correlates of Sedentary Behavior in Older Adults

Maya N. White, ­Abby C. King, James F. Sallis et al. · Journal of Aging and Health · 2015 · 19 citations

Education, Geriatric Medicine, Health Behavior +13

Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib

Maya N. White, Andrew J. Piper‐Vallillo, Rebecca M. Gardner et al. · Clinical Lung Cancer · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +11

Effects of fish oil supplementation on eicosanoid production in patients at higher risk for colorectal cancer

Maya N. White, Martha J. Shrubsole, Qiuyin Cai et al. · European Journal of Cancer Prevention · 2019 · 16 citations · Full text

Medicine, Nutrition, Oncology +13